Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Levonorgestrel adverse reaction (disorder) |
Causative agent (attribute) |
True |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing levonorgestrel (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to levonorgestrel |
Causative agent (attribute) |
False |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Levonorgestrel [combined oral contraceptive] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Levonorgestrel [progestogen contraceptive] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Levonorgestrel 30 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Levonorgestrel 52mg intrauterine system (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely levonorgestrel 750 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Levonorgestrel 37.5 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing levonorgestrel 0.75 mg/1 each oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely ethinylestradiol 20 microgram and levonorgestrel 100 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ethinylestradiol 30 microgram and levonorgestrel 50 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 125 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ethinyl estradiol + levonorgestrel 0.03mg/0.15mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ethinylestradiol 40 microgram and levonorgestrel 75 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ethinyl oestradiol + levonorgestrel 0.05mg/0.25mg pills |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ethinyl estradiol + levonorgestrel 0.15mg/0.03mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Levonorgestrel 0.015mg/day + estradiol 0.045mg/day transdermal system |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Climara pro |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Levonorgestrel + estradiol transdermal system |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Climara pro levonorgestrel 0.015mg/day + estradiol 0.045mg/day transdermal system |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing ethinylestradiol and levonorgestrel (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Levonorgestrel 1.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lutera 28 tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ethinylestradiol 30 microgram and levonorgestrel 150 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Levonorgestrel 75 mg prolonged-release subcutaneous implant |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing estradiol and levonorgestrel (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely ethinylestradiol 20 microgram and levonorgestrel 90 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Levonorgestrel-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing levonorgestrel in topical dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Allergy to levonorgestrel |
Causative agent (attribute) |
True |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Levonorgestrel-releasing intrauterine system |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Levonorgestrel-releasing implant |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Levonorgestrel 30 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Levonorgestrel 30 microgram oral tablet |
Has basis of strength substance (attribute) |
True |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely levonorgestrel 750 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely levonorgestrel 750 microgram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Levonorgestrel 37.5 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Levonorgestrel 37.5 microgram oral tablet |
Has basis of strength substance (attribute) |
True |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing levonorgestrel 0.75 mg/1 each oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing levonorgestrel 0.75 mg/1 each oral tablet |
Has basis of strength substance (attribute) |
False |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Levonorgestrel 1.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Levonorgestrel 1.5 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol 30 microgram and levonorgestrel 150 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Ethinylestradiol 30 microgram and levonorgestrel 150 microgram oral tablet |
Has basis of strength substance (attribute) |
True |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely ethinylestradiol 20 microgram and levonorgestrel 100 microgram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol 30 microgram and levonorgestrel 50 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol 30 microgram and levonorgestrel 50 microgram oral tablet |
Has basis of strength substance (attribute) |
False |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 125 microgram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol 40 microgram and levonorgestrel 75 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol 40 microgram and levonorgestrel 75 microgram oral tablet |
Has basis of strength substance (attribute) |
False |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinyl oestradiol + levonorgestrel 0.05mg/0.25mg pills |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Ethinyl oestradiol + levonorgestrel 0.05mg/0.25mg pills |
Has basis of strength substance (attribute) |
False |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely ethinylestradiol 20 microgram and levonorgestrel 90 microgram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely ethinylestradiol 20 microgram and levonorgestrel 100 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely ethinylestradiol 20 microgram and levonorgestrel 100 microgram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Ethinylestradiol 40 microgram and levonorgestrel 75 microgram oral tablet |
Has basis of strength substance (attribute) |
True |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely ethinylestradiol 20 microgram and levonorgestrel 90 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely ethinylestradiol 20 microgram and levonorgestrel 90 microgram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Ethinylestradiol 30 microgram and levonorgestrel 150 microgram oral tablet |
Has basis of strength substance (attribute) |
False |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 125 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 125 microgram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Ethinylestradiol+levonorgestrel 30micrograms/250micrograms tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol+levonorgestrel 30micrograms/250micrograms tablet (substance) |
Has basis of strength substance (attribute) |
False |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol 50 microgram and levonorgestrel 250 microgram oral tablet |
Has basis of strength substance (attribute) |
True |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Ethinylestradiol 50 microgram and levonorgestrel 250 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol 50 microgram and levonorgestrel 250 microgram oral tablet |
Has basis of strength substance (attribute) |
False |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Levonorgestrel 37.5 microgram oral tablet |
Has precise active ingredient |
True |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely levonorgestrel 750 microgram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Levonorgestrel 1.5 mg oral tablet |
Has precise active ingredient |
True |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Levonorgestrel 30 microgram oral tablet |
Has precise active ingredient |
True |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely ethinylestradiol 20 microgram and levonorgestrel 100 microgram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
False |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 125 microgram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
False |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol 40 microgram and levonorgestrel 75 microgram oral tablet |
Has precise active ingredient |
True |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Ethinylestradiol 50 microgram and levonorgestrel 250 microgram oral tablet |
Has precise active ingredient |
True |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely ethinylestradiol 20 microgram and levonorgestrel 90 microgram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
False |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol+levonorgestrel 30micrograms/250micrograms tablet (substance) |
Has precise active ingredient |
False |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol- and levonorgestrel-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Ethinylestradiol 30 microgram and levonorgestrel 50 microgram oral tablet |
Has precise active ingredient |
False |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol 30 microgram and levonorgestrel 150 microgram oral tablet |
Has precise active ingredient |
False |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing levonorgestrel in subcutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Levonorgestrel-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing estradiol and levonorgestrel in transdermal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Levonorgestrel-containing product in intrauterine dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only estradiol and levonorgestrel (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol and levonorgestrel only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only levonorgestrel (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Estradiol and levonorgestrel only product in transdermal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only levonorgestrel in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only ethinylestradiol and levonorgestrel in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only levonorgestrel in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only levonorgestrel in intrauterine dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Levonorgestrel only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Levonorgestrel 75 mg prolonged-release subcutaneous implant |
Has precise active ingredient |
True |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Levonorgestrel 75 mg prolonged-release subcutaneous implant |
Has basis of strength substance (attribute) |
True |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Levonorgestrel 833 nanogram/hour prolonged-release intrauterine drug delivery system |
Has precise active ingredient |
True |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Levonorgestrel 833 nanogram/hour prolonged-release intrauterine drug delivery system |
Has basis of strength substance (attribute) |
True |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only levonorgestrel in subcutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Estradiol 1.88 microgram/hour and levonorgestrel 625 nanogram/hour prolonged-release transdermal patch |
Has precise active ingredient |
True |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Estradiol 1.88 microgram/hour and levonorgestrel 625 nanogram/hour prolonged-release transdermal patch |
Has basis of strength substance (attribute) |
True |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Levonorgestrel-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levonorgestrel (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |